Resgen Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003804,
    "name": "Resgen",
    "stock_name": "Resgen",
    "full_name": "Resgen Ltd",
    "name_url": "stocks-analysis/resgen",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "63.80",
    "chg": -1.2,
    "chgp": "-1.85%",
    "dir": -1,
    "prev_price": "65.00",
    "mcapval": "136.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543805,
    "symbol": "",
    "ind_name": "Oil",
    "ind_code": 19,
    "indexname": "",
    "isin": "INE0NYN01016",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": 37500,
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/resgen-1003804-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Resgen overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-resgen-overvalued-or-undervalued-3713733",
        "imagepath": "",
        "date": "2025-11-19 08:12:10",
        "description": "As of 18 November 2025, the valuation grade for Resgen has moved from fair to very attractive, indicating a significant improvement in its valuation outlook. The company is currently assessed as undervalued. Key ratios supporting this assessment include a PE ratio of 20.29, an EV to EBITDA ratio of 10.32, and a PEG ratio of 0.95, all of which suggest that Resgen is priced favorably compared to its earnings growth potential.\n\nIn comparison to its peers, Resgen's valuation metrics stand out. For instance, Larsen & Toubro has a much higher PE ratio of 34.3, and CG Power & Industries is deemed very expensive with a PE of 108.1. This places Resgen in a more attractive position relative to its industry, particularly given its solid ROCE of 20.21% and ROE of 12.95%. Despite recent stock performance lagging behind the Sensex, with a year-to-date decline of 33.99% compared to the Sensex's gain of 8.36%, the underlyi..."
      },
      {
        "title": "How has been the historical performance of Resgen?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-resgen-3704204",
        "imagepath": "",
        "date": "2025-11-15 00:28:42",
        "description": "Answer:\nThe historical performance of Resgen shows significant growth in net sales and profitability over the years, particularly from March 2021 to March 2025.\n\nBreakdown:\nResgen's net sales have increased dramatically from 0.02 crore in March 2021 to 65.16 crore in March 2025, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 0.02 crore in March 2021 to 65.16 crore in March 2025. The company's total expenditure also grew, from 0.01 crore in March 2021 to 49.78 crore in March 2025, with raw material costs being the largest component. Operating profit (PBDIT) has shown consistent improvement, reaching 15.38 crore in March 2025, up from just 0.01 crore in March 2021. Profit before tax increased from 0.01 crore in March 2021 to 11.14 crore in March 2025, and profit after tax rose to 7.98 crore in March 2025 from 0.01 crore in March 2021. The company's total as..."
      },
      {
        "title": "When is the next results date for Resgen?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-resgen-3691273",
        "imagepath": "",
        "date": "2025-11-11 23:20:42",
        "description": "The next results date for Resgen is scheduled for 14 November 2025...."
      }
    ],
    "total": 71,
    "sid": "1003804",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/resgen-1003804"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "12-Jan-2026",
      "details": "Certificate under Regulation 74(5) of the SEBI (Depository and Participants) Regulations 2018 for the Quarter ended 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held For Consideration And Approval Of The Unaudited Financial Results For The Half Year Ended 30Th September 2025",
      "datetime": "14-Nov-2025",
      "details": "Outcome of Board Meeting held for consideration and approval of the unaudited Financial Results for the half year ended 30th September 2025",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of Board Meeting Held For Consideration And Approval Of The Unaudited Financial Results For The Half Year Ended 30Th September 2025",
      "datetime": "14-Nov-2025",
      "details": "Approval of the unaudited Financial Results for the half year ended on 30th September 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Resgen overvalued or undervalued?

2025-11-19 08:12:10

As of 18 November 2025, the valuation grade for Resgen has moved from fair to very attractive, indicating a significant improvement in its valuation outlook. The company is currently assessed as undervalued. Key ratios supporting this assessment include a PE ratio of 20.29, an EV to EBITDA ratio of 10.32, and a PEG ratio of 0.95, all of which suggest that Resgen is priced favorably compared to its earnings growth potential. In comparison to its peers, Resgen's valuation metrics stand out. For instance, Larsen & Toubro has a much higher PE ratio of 34.3, and CG Power & Industries is deemed very expensive with a PE of 108.1. This places Resgen in a more attractive position relative to its industry, particularly given its solid ROCE of 20.21% and ROE of 12.95%. Despite recent stock performance lagging behind the Sensex, with a year-to-date decline of 33.99% compared to the Sensex's gain of 8.36%, the underlyi...

How has been the historical performance of Resgen?

2025-11-15 00:28:42

Answer: The historical performance of Resgen shows significant growth in net sales and profitability over the years, particularly from March 2021 to March 2025. Breakdown: Resgen's net sales have increased dramatically from 0.02 crore in March 2021 to 65.16 crore in March 2025, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 0.02 crore in March 2021 to 65.16 crore in March 2025. The company's total expenditure also grew, from 0.01 crore in March 2021 to 49.78 crore in March 2025, with raw material costs being the largest component. Operating profit (PBDIT) has shown consistent improvement, reaching 15.38 crore in March 2025, up from just 0.01 crore in March 2021. Profit before tax increased from 0.01 crore in March 2021 to 11.14 crore in March 2025, and profit after tax rose to 7.98 crore in March 2025 from 0.01 crore in March 2021. The company's total as...

When is the next results date for Resgen?

2025-11-11 23:20:42

The next results date for Resgen is scheduled for 14 November 2025....

View All News